Although it has been hypothesized that depressive persons have an excess risk of cancer, few prospective data are available. The association between depressiveness and subsequent incidence of lung cancer was studied in the nationally representative Mini-Finland Health Survey. The study population comprised 7,018 adult men and women, free from cancer at the baseline, earned out in [1978][1979][1980]. Dunng a 14-year follow-up, 605 cancer cases occurred, of which 70 were male lung cancer patients. Mental problems and disorders were assessed at the baseline examination using standard interview techniques (General Health Questionnaire and Present State Examination). The relative risk of lung cancer between depressive persons and individuals with a normal depressiveness score was 3.32 (95% confidence interval 1.53-7.20). Neither adjustment for the potential confounding factors of age, education, geographic area, smoking, alcohol consumption, body mass index, serum cholesterol, leisure-time exercise, general health, and use of antidepressant medication nor exclusion of cancer cases occurring during the first 4 years of follow-up notably altered the results. There was a strong interaction between depressiveness and smoking. The relative nsks of lung cancer between smokers and nonsmokers were 3.38 (95% confidence interval 1.09-10 52) at normal depressiveness score levels and 19.67 (95% confidence interval 2.57-150.7) at strongly elevated levels, respectively It is possible that depressiveness modifies the effect of smoking on lung cancer risk either by biologic mechanisms or by affecting smoking behavior. Am J Epidemiol 1996;144:1096-103.
It has been suggested that depression causes alterations in the immune system, thus elevating the risk of immune-related disorders including cancer (1) . As depressiveness also affects behavior, a depressive person tends to have more risk factors for cancer. For example, depression plays an important role in the dynamics of cigarette smoking (2) . Although considerable interest has focused on the role of depression in the etiology of cancer, most published studies have been retrospective, suffering in addition from several methodological weaknesses (3, 4) . The evidence of an association between depression and cancer occurrence posited in the more reliable prospective studies is also inconclusive, presenting both a weak association (5-7) and a lack of association (4, (8) (9) (10) (11) (12) (13) (14) . The lack of association found in prospective studies may possibly have been due in part to the fact that they generally concentrated on all cancer sites combined, thus weakening possible associations of specific sites with specific risk factors.
We examined the association between depression and subsequent lung cancer occurrence, with special emphasis on the major risk factor, smoking, in a cohort representing the Finnish population during an 11-to 14-year follow-up time.
MATERIALS AND METHODS
The Mini-Finland Health Survey was carried out in 1978-1980 by the Mobile Clinic of the Social Insurance Institution in 40 areas of Finland. The two-stage random sample drawn from the population register to represent Finnish adults aged 30 years and over (15) comprised 8,000 persons (3,637 men and 4,363 women) from 69 municipalities. A total of 7,219 persons, 90 percent of the sample, participated. Question-naires were supplied, and interviews covering symptoms, diseases, medication, smoking status, alcohol consumption, and exercise were carried out. Blood samples were taken for serologic studies, and levels of serum cholesterol were determined. Chest radiographic examinations were taken and subsequently read by a radiologist to screen for chronic respiratory and cardiovascular diseases. Body height and weight were measured, and the body mass index (weight (kg)/height (m) 2 ) was used as a measure of relative weight. Subjects were classified according to smoking status as never smokers; exsmokers; smokers of pipes or cigars; and smokers of <10 cigarettes/day, 10-19 cigarettes/day, 20-29 cigarettes/day, and >30 cigarettes/day.
The subjects were interviewed about their respiratory symptoms using a standard formula of the British Medical Research Council; symptoms of chronic bronchitis were considered to be present if the subject reported expectorating phlegm during most days of a 3-month annual period (16) . Lung function was studied with spirometry (Vitalograph spirometer and Vitalograph digital meter; Vitalograph Limited, Buckingham, England). Forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV,) were measured. The FEVj/FVC quotient (percentage) was used as a measure of expiratory flow. Results of two technically faultless measures were recorded and corrected to values of body temperature and pressure, saturated with water vapor; the highest reading was taken as the final result. Specially trained laboratory nurses made the measurements using the same apparatus throughout the study. The subjects with disease history, symptoms, or findings suggesting cardiovascular or respiratory diseases were asked to participate in the reexamination. This phase consisted of a standardized physical examination carried out by specially trained physicians working according to detailed written instructions and applying uniform diagnostic criteria (15) . The diagnosis of pulmonary emphysema was based mainly on findings in chest radiographs and in the standardized physical examination.
The main screening method for mental problems was the 36-item version of the General Health Questionnaire (17) , and the main diagnostic method was the short version of the Present State Examination (18), a standardized psychiatric interview schedule. The Present State Examination interview was conducted by a specially trained and supervised nurse. The psychiatric diagnoses are based mainly on the Present State Examination as evaluated using the CATEGO program (18) . To obtain complete data on psychoses, we amended the diagnoses based on the Present State Examination with information obtained from mental institutions and other sources (19) . For the analysis, the diagnoses were grouped psychoses, neurotic depression, other neuroses, and other psychiatric diagnoses. To assess the degree of depressiveness, we calculated a score based on 18 functional depressionrelated items of the 36-item General Health Question-naire (see Appendix) (17) . The score describes depressiveness during the last few weeks, including major episodes and dysthymia signs (20) . The alternative answers to the questions were 1) better than usual/ none at all, 2) same as usual, 3) rather more than usual, and 4) much more than usual/definitely has occurred. The depressiveness score for each individual was formed as the arithmetic mean of all answers. The repeatability of the General Health Questionnaire is relatively good as the intraclass correlation coefficient was reported to be 0.79 (21) . The agreement between depressiveness and clinical depression was not complete: 29 percent of the persons with a high depressiveness score of 2.5-4.0 suffered from clinical depression, and 57 percent of the persons with clinical depression expressed depressiveness with a score of 2.5-4.0.
A unique personal identification number was used to link the data contained in the health examination data set with those of the nationwide Finnish Cancer Registry (22) . The registry receives information from hospitals, practitioners, pathologic laboratories, and death certificates. It has been obligatory to report every cancer case to the registry since 1961, and its coverage is virtually complete (22) . Thus, all participants with cancer diagnosed between the date of the baseline examination and the end of 1991 were identified among the 7,018 persons at risk after exclusion of the persons suffering from cancer at baseline. The site of the primary cancer and the date of the cancer diagnosis were obtained from the Cancer Registry. During the maximum 14-year follow-up, 605 new primary cancer cases occurred, of which 70 were male and six were female lung cancer cases. The male lung cancer cases comprised 22 squamous cell carcinomas, 13 small cell carcinomas, 17 other carcinomas, and 18 with unknown histology. Because of the small number of female lung cancer cases, the focus was on men. The association between diagnosed depression and depressiveness and lung cancer risk was estimated using Cox's proportional hazards model (23) . Confounding and effect-modifying factors were included in the model, and the relative risks of lung cancer were estimated between psychiatric diagnosis and arbitrarily chosen classes of the depressiveness score. ever, a significantly elevated risk of lung cancer among men with psychosis. Nonsignificant increases in the risks of male lung cancer and female breast cancer were observed among persons with clinical depression.
Men with high depressiveness scores had a significantly elevated risk of lung cancer. No such associations were found for all sites of cancer combined or for female breast cancer (table 2). The lung cancer incidence increased with age and with the consumption of cigarettes, but it also varied according to risk factors other than smoking (table 3) . Divorced or lean men, those with symptoms of chronic bronchitis, emphysema, or a low FEVj/FVC ratio, and those not reporting good general health had a significantly elevated risk of lung cancer.
Most risk determinants of lung cancer were associated with the depressiveness score (table 3). Of those men with low scores (values under 1.50), 33.7 percent had never smoked, 34.3 percent were exsmokers, and 32.0 percent were current smokers. The corresponding percentages of the men with high scores (values 2.50 or higher) were 18.8, 32.5, and 48.9, respectively.
The depressiveness score significantly predicted the incidence of lung cancer. The age-adjusted relative risk between men with scores of 2.50-4.00 compared with men with scores below 1.50 was 3.32 (95 percent confidence interval 1.53-7.20). Adjustment for other potential confounding factors, inclusion of cancer cases occurring only after a 4-year follow-up, and exclusion of persons using antidepressant medication did not notably alter the results (table 4) . Combination of the depressiveness score of 2.50-4.00 and the clinical diagnosis of depression into one category did not strengthen the association, giving a relative risk of 2.05 (95 percent confidence interval 1.14-3.64) compared with the risk of other men.
Depressiveness was not associated with squamous cell lung cancer incidence. The age-adjusted relative risk of squamous lung cancer between men with scores of 2.50-4.00 compared with men with scores below 1.50 was 1.07 (95 percent confidence interval 0.27-4.32). The corresponding relative risk of other lung carcinomas and those with unspecified histology combined was 3.89 (95 percent confidence interval 1.43-10.53).
There was a strong interaction between smoking status and depressiveness score (table 5). The ageadjusted relative risk of lung cancer was 3.38 (95 percent confidence interval 1.09-10.52) between current smokers and nonsmokers with depressiveness score levels below 1.50, whereas the corresponding rate for men with levels of 2.50 or more was 19.67 (95 percent confidence interval 2.57-150.7). Exclusion of lung cancer cases occurring during the first 4 years or of men using antidepressant medication did not notably alter the results nor did adjustment for potential confounding factors materially weaken the strength of the association (data not shown).
DISCUSSION
Although some prospective studies (5-7) have reported significant associations between depressiveness and the occurrence of all sites of cancer, the present follow-up study, in accordance with the majority of similar studies (4, 8, (10) (11) (12) (13) (14) , found no significant association with respect to clinical depression or depressiveness. Like Hahn and Petitti (9), we found no association between depressiveness and breast cancer occurrence in this study either.
Depressiveness was associated with the incidence of lung cancer in the present study. The association persisted after adjustment for known major risk factors of the disease, being in line with the hypothesis of an * Adjusted for age and smoking status (number at risk = 3,239; number of cases » 70). t Adjusted for age, smoking status, body mass Index, serum cholesterol, alcohol consumption, use of antidepressant medication, education, marital status, geographic area, general health, leisure-time exercise, symptoms of chronic bronchitis, emphysema, and forced expiratory volume In 1 second/forced vital capacity (number at risk •= 3,225; number of cases = 70).
t Adjustment for age and smoking; exclusion of cancer cases occurring during the first 4 years (number at risk = 2,973; number of cases = 49).
§ Adjustment for age and smoking; exclusion of persons using antidepressant medication (number at risk = 3,204; number of cases = 68). independent effect of depressiveness. In accordance with a previous study on smoking-related cancers (4), the association between the depressiveness score and lung cancer was present only among smokers. Our finding suggests, furthermore, that the degree of depressiveness modulates the excess risk of smoking; smoking is a stronger risk factor for depressive than for nondepressive persons. The finding of this study corroborates the hypothesis that depressiveness is a risk factor for lung cancer. Some published studies suggest that depression affects the immune and hormonal systems (1), possibly leading to an increased cancer risk. There are, however, several alternative interpretations to the association observed. One feature of depression and depressiveness is "negative thinking," which may promote serfdestroying behavior (24, 25) . Depression may thus affect the behavioral risk factors of lung cancer or the association between other risk factors and lung cancer. Although we adjusted for several potential confounding factors, we could not fully exclude the possibility that the associations observed were still due to confounding caused by unsatisfactory control of factors closely correlated with depressiveness. Some dietary factors, for example, are thought to be associated with lung cancer risk (26) and may also be different for depressive and nondepressive persons, thus confounding the association.
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It has been suggested on the basis of animal models that some antidepressive drugs may influence the course or development of cancer (27) . One human follow-up study on two antidepressants did not confirm this (13) whereas another, as did ours, found a suggestive nonsignificant association (28) . However, adjustment for the use of depressive drugs or exclusion of users of antidepressive agents did not notably alter the main results of the present study, suggesting that this factor is of minor significance as a confounding factor.
The risk of cancer in depressed persons may be elevated via mechanisms associated with smoking, which is the major risk factor for lung cancer. Depressive persons less prone to quit smoking than nondepressive persons (2, 29, 30) may continue smoking more frequently during the follow-up than the nondepressive group, even within the baseline smoking categories (31) . However, the baseline prevalence of quitters did not differ between the depressive and nondepressive groups in the population of our study. It is also possible that depressive smokers may smoke more or inhale the smoke more intensively than nondepressive smokers and thus have an elevated risk of lung cancer. In this study, we adjusted for the number of cigarettes consumed a day, thus reducing this source of bias.
Cancer may cause depressive symptoms and even clinical depression (10) . Although the degree of depressiveness was determined before the diagnosis of lung cancer in the population free from cancer at baseline, it was still possible that occult cancer could be responsible for the association. To minimize this potential source of bias, we excluded cancer cases occurring during the first 4 years of follow-up. After the exclusion, the association between depressiveness and lung cancer persisted. Predecessors of lung cancer, e.g., chronic bronchitis, emphysema, impaired lung function, and a general feeling of ill health, may also trigger depression, but an adjustment for these conditions did not substantially affect the depression-cancer association.
Finally, certain factors remain that may have obscured the association between depressiveness and lung cancer occurrence and that may be common causes or clustering of chronic diseases in the same population groups (32) . During the follow-up, changes in depressiveness, of the validity and reliability of the depressiveness score, or of smoking status may also have altered the associations.
In conclusion, our results suggest that depressiveness may modify the effect of smoking on lung cancer occurrence. Large-scale follow-up studies, in particular, are needed to shed more light on whether this influence is attributable to biologic effects of depression or merely to differences in smoking habits between depressive and nondepressive persons.
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